INTRODUCTION
Confidence in cumulative evidence 17 Describe how the strength of the body of evidence will be assessed (such as GRADE) See page 9, lines 224-225 * It is strongly recommended that this checklist be read in conjunction with the PRISMA-P Explanation and Elaboration (cite when available) for important clarification on the items. Amendments to a review protocol should be tracked and dated. The copyright for PRISMA-P (including checklist) is held by the PRISMA-P Group and is distributed under a Creative Commons Attribution Licence 4.0. 85. (notif* adj2 (automat* or comput* or digit* or e mail or electronic or email or software or system* or sms or 89. ((RIFLE or risk injury failure loss) and (alarm* or alert* or information system* or messag* or notif* or remind* or 113 reporting system* or warn*)).tw,kf.
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90. (serum creatinine and (alarm* or alert* or information system* or messag* or notif* or remind* or reporting system* 115 or warn*)).tw,kf. 
